NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 7.27% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 5.46% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 5.36% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 5.28% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.26% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 5.19% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.06% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.75% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.75% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 4.65% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 4.12% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 3.69% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.67% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.65% |
| VCYT | Veracyte Inc | Healthcare | Diagnostics & Research | 3.34% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.21% |